Literature DB >> 20171714

Cross-species comparison of fluoxetine metabolism with fish liver microsomes.

Emily M Smith1, Shaogang Chu, Gordon Paterson, Chris D Metcalfe, Joanna Y Wilson.   

Abstract

Pharmaceuticals discharged in municipal wastewater are of emerging concern because of their potential for inducing biological effects in aquatic organisms. Selective serotonin reuptake inhibitors (SSRIs), pharmaceuticals prescribed to treat chronic depression, have been detected in receiving and wastewaters. Fluoxetine is a highly prescribed model SSRI used to assess impacts of antidepressants on aquatic organisms. In this study, in vitro hepaticfluoxetine metabolism was determined in several model fish species: rainbow trout, goldfish, zebrafish and killifish. Incubation of fluoxetine with hepatic microsomes from trout pre-treated with carbamazepine showed a time-dependant loss of fluoxetine, concomitant with an increase in norfluoxetine, the major mammalian demethylated metabolite. However, fluoxetine was not well metabolized in reactions with hepatic microsomes from untreated fish. Fluoxetine loss was greater than norfluoxetine production, indicating that norfluoxetine is not the predominant fluoxetine biotransformation product in fish. Furthermore, norfluoxetine was often undetected, possibly indicating that fluoxetine demethylation is a minor metabolic pathway in fish. Inter-species differences in fluoxetine metabolism were not evident because of high intra-species variability, although killifish appeared to have the highest hepatic metabolic capacity for fluoxetine. Fluoxetine metabolism in mammals is catalyzed by cytochrome P450 (CYP) enzymes. Trout were exposed to knownCYP inducers, carbamazepine and 3-methylcholanthrene, to assess potential induction of hepatic fluoxetine metabolism. Microsomes from 3-methylcholanthrene treated fish did not induce detectable changes in fluoxetine concentrations in vitro, indicating that fish CYP1s are not involved in fluoxetine metabolism; the CYPs involved are still unclear. Identification of metabolites other than norfluoxetine warrants further investigation. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171714     DOI: 10.1016/j.chemosphere.2010.01.058

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  6 in total

Review 1.  Occurrence of PPCPs in the marine environment: a review.

Authors:  Lauren Arpin-Pont; Maria Jesus Martinez Bueno; Elena Gomez; Hélène Fenet
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-26       Impact factor: 4.223

Review 2.  Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals.

Authors:  Thomas H Hutchinson; Judith C Madden; Vinny Naidoo; Colin H Walker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-19       Impact factor: 6.237

3.  Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance.

Authors:  Matthew G Baron; Kate S Mintram; Stewart F Owen; Malcolm J Hetheridge; A John Moody; Wendy M Purcell; Simon K Jackson; Awadhesh N Jha
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

4.  Temperature-Dependent Residue Depletion Regularities of Tiamulin in Nile Tilapia (Oreochromis niloticus) Following Multiple Oral Administrations.

Authors:  Cuiyv Cao; Yongtao Liu; Guodong Zhang; Jing Dong; Ning Xu; Shun Zhou; Yibin Yang; Qiuhong Yang; Xiaohui Ai
Journal:  Front Vet Sci       Date:  2021-06-11

5.  Enantioselective transformation of fluoxetine in water and its ecotoxicological relevance.

Authors:  María Jesús Andrés-Costa; Kathryn Proctor; Marco T Sabatini; Anthony P Gee; Simon E Lewis; Yolanda Pico; Barbara Kasprzyk-Hordern
Journal:  Sci Rep       Date:  2017-11-17       Impact factor: 4.379

6.  Development of a method for assessing the accumulation and metabolization of antidepressant drugs in zebrafish (Danio rerio) eleutheroembryos.

Authors:  Noemí Molina-Fernández; Sandra Rainieri; Riansares Muñoz-Olivas; Paloma de Oro-Carretero; Jon Sanz-Landaluze
Journal:  Anal Bioanal Chem       Date:  2021-06-30       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.